CAMBRIDGE, Mass., May 30, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Jefferies 2012 Global Healthcare Conference in New York City. Marc D. Beer, CEO of Aegerion, is scheduled to present on Wednesday, June 6, 2012 at 8:30 a.m. ET.
